HuagongsheHuagongshe Chemistry Print Report · For research reference only
1-(5-Methyl-[1,3,4]oxadiazol-2-yl)-piperidin-4-one → [8-(4-Fluoro-3-trifluoromethyl-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-[1-(5-methyl-[1,3,4]oxadiazol-2-yl)-piperidin-4-yl]-amine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 1-(5-Methyl-[1,3,4]oxadiazol-2-yl)-piperidin-4-one | HCID 58397853 | — |
| Reactant | 8-(4-Fluoro-3-trifluoromethyl-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine | HCID 67344042 | — |
| Product | [8-(4-Fluoro-3-trifluoromethyl-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-[1-(5-methyl-[1,3,4]oxadiazol-2-yl)-piperidin-4-yl]-amine | HCID 58397902 | — |
Reaction Steps
Prepared in analogy to example 1h employing 1-(5-methyl-[1,3,4]oxadiazol-2-yl)-piperidin-4-one (see example 25b) and 8-(4-fluoro-3-trifluoromethyl-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine (prepared in analogy to example 1d-g). The title compound was obtained as brown solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08486967B2 |
| Source dataset | uspto-grants-2013_07 |
| ORD ID | ord-81b22a52582e4d8196337ef22b5e08c4 |
| Source note | uspto-grants-2013_07 |